Sign In
Buy TLSA
$1.03
+0.0600 (+6.19%)
At Close: Jul 31, 2026
NEW YORK and LONDON, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and
NEW YORK and LONDON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for
Tiziana Life Sciences plc ("Tiziana" or the "Company") - AIM Delisting and Admission to the Standard Listing Segment of Main Market
02:00am, Wednesday, 20'th Jan 2021
NEW YORK and LONDON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeu
Tiziana announces appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer
02:00am, Wednesday, 13'th Jan 2021
NEW YORK and LONDON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeu
Tiziana Life Sciences to participate at J.P. Morgan Healthcare Conference 2021
12:08pm, Monday, 11'th Jan 2021
NEW YORK and LONDON, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics fo
Tiziana Life Sciences to Present at Biotech Showcase Digital 2021
09:48am, Monday, 11'th Jan 2021
NEW YORK and LONDON, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics fo
NEW YORK and LONDON, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeu
Tiziana Life Sciences PLC (“Tiziana” or “the Company”) - Publication of Prospectus
06:38am, Friday, 18'th Dec 2020
This announcement is an advertisement and not a prospectus. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitme
LONDON and NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for
Westwater Resources Is a Creative Bet on Electric Vehicles
02:01pm, Tuesday, 08'th Dec 2020
Westwater Resources is a natural resources mining company. But WWR stock is also an interesting way to invest in the electric vehicle wave.
Tiziana Life Sciences to Host Investor Update Call on 2 December 2020 at 4:15 p.m. ET
02:00am, Tuesday, 01'st Dec 2020
NEW YORK and LONDON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, i
Tiziana Life Sciences PLC ("Tiziana" or the "Company") - PDMR Dealing
10:16am, Wednesday, 18'th Nov 2020
LONDON and NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for
Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn's Disease
02:00am, Wednesday, 11'th Nov 2020
First Ever Study with take-home capsules of Foralumab , a Fully Human Anti-CD3 Monoclonal Antibody
Tiziana Enters Human Trials for Covid-19 Treatment
02:36pm, Monday, 02'nd Nov 2020
Nov.02 -- Tiziana Life Sciences PLC is launching a clinical trial in Brazil involving humans where they will be treated with a nasally administered Foralumab, a monoclonal antibody. Gabriele Cerrone,
Tiziana Life Sciences plc
